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gonadotrope cell lines
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and Pamela L. Mellon1*
Abstract
Background: Proper expression of key reproductive hormones from gonadotrope cells of the pituitary is required
for pubertal onset and reproduction. To further our understanding of the molecular events taking place during
embryonic development, leading to expression of the glycoproteins luteinizing hormone (LH) and follicle-
stimulating hormone (FSH), we characterized chromatin structure changes, imparted mainly by histone
modifications, in model gonadotrope cell lines.
Methods: We evaluated chromatin status and gene expression profiles by chromatin immunoprecipitation assays,
DNase sensitivity assay, and RNA sequencing in three developmentally staged gonadotrope cell lines, αT1–1
(progenitor, expressing Cga), αT3–1 (immature, expressing Cga and Gnrhr), and LβT2 (mature, expressing Cga, Gnrhr,
Lhb, and Fshb), to assess changes in chromatin status and transcription factor access of gonadotrope-specific genes.
Results: We found the common mRNA α-subunit of LH and FSH, called Cga, to have an open chromatin
conformation in all three cell lines. In contrast, chromatin status of Gnrhr is open only in αT3–1 and LβT2 cells. Lhb
begins to open in LβT2 cells and was further opened by activin treatment. Histone H3 modifications associated
with active chromatin were high on Gnrhr in αT3–1 and LβT2, and Lhb in LβT2 cells, while H3 modifications
associated with repressed chromatin were low on Gnrhr, Lhb, and Fshb in LβT2 cells. Finally, chromatin status
correlates with the progressive access of LHX3 to Cga and Gnrhr, followed by PITX1 binding to the Lhb promoter.
Conclusion: Our data show the gonadotrope-specific genes Cga, Gnrhr, Lhb, and Fshb are not only controlled by
developmental transcription factors, but also by epigenetic mechanisms that include the modulation of chromatin
structure, and histone modifications.
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Background
The pituitary arises from the closure of Rathke’s pouch on
mouse embryonic day 12 (E12.5), giving rise to five endo-
crine cell types: gonadotropes, lactotropes, corticotropes,
thyrotropes, and somatotropes. The development of these
specialized cells depends on a stringent temporal and
spatial control of transcription factors [1, 2]. The gonado-
tropes emerge late in development at ~E16.5, and
comprise ~10–20% of pituitary cells in adulthood. The
major role of gonadotropes is to regulate puberty and fer-
tility through the synthesis and secretion of luteinizing
hormone (LH) and follicle-stimulating hormone (FSH).
FSH and LH are dimeric glycoproteins, formed from an α
and a β subunit. The β subunit is distinct for each
hormone, and is transcribed from separate genes. Gona-
dotrope cells can be traced throughout pituitary develop-
ment by the sequential appearance of early lineage
markers. First the mRNA for the common α-subunit of
LH and FSH (Cga, glycoprotein hormones also known as
αGSU) is detectable at E11.5 in the mouse, followed by
the nuclear receptor Steroidogenic Factor 1 (Sf1 or
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Nr5a1), and the gonadotropin-releasing hormone receptor
(Gnrhr). Finally, the gonadotropin hormone beta subunit
mRNAs emerge at E16.5 for Lhb and E17.5 for Fshb [3].
Specification of cell fate is controlled by a combination
of transcription factors acting on cis-regulatory ele-
ments, as well as epigenetic mechanisms that include
the modulation of chromatin structure [4, 5]. Gene acti-
vation and repression are specifically regulated through
changes in chromatin structure imparted mainly by his-
tone modifications and DNA methylation. Inactive genes
typically display condensed chromatin that is resistant to
DNaseI digestion, and show histone H3 deacetylation
and methylation [6, 7]. Active genes and regulatory ele-
ments are often in an open chromatin conformation to
facilitate binding of regulatory proteins.
The access of transcription factors to the chromatin re-
quires the relaxation of chromatin, leading to an open
conformation and increased sensitivity to DNAseI diges-
tion [8–10]. The regulation of chromatin status is complex
and its analysis requires multiple complementary
approaches. Open chromatin is often associated with
acetylation at histone H3 and tri-methylation at histone
H3-lysine 4 (H3K4) [6, 7]. In addition, certain combina-
tions of histone modifications are thought to distinguish
different regions within a given gene, i.e., promoters ver-
sus enhancers. For example, active promoters show high
levels of tri-methylation and low levels of mono-
methylation at H3K4; whereas enhancers show the oppos-
ite methylation pattern at H3K4 [11]. The dynamic nature
of chromatine modifications, are key in they role to con-
trol chromatine compaction and gene expression. Indeed,
histone deacetylases (HDAC) allow histone deacetylation,
leading to chromatin compaction [12, 13]. The conversion
of chromatin from an inactive to active state at genes in-
volved in differentiation is thought to promote the matur-
ation of progenitor and precursor cells, however the
chromatin status changes taking place during gonadotrope
maturation are still poorly understood due to the complex
cell composition of the pituitary.
Molecular investigation of the regulation of gonadotrope
gene expression has been greatly facilitated by the use of
well-characterized, cultured cell lines that represent differ-
ent maturation stages of gonadotropes [14–17]. The αT1–
1 cell line represents a progenitor to the gonadotrope
and/or thyrotrope lineages [15] and expresses the single
common glycoprotein hormone subunit gene, Cga [18].
The immature gonadotrope αT3–1 cell line expresses
both Cga and Gnrhr, and the mature gonadotrope LβT2
cell line expresses all four gonadotrope-specific genes Cga,
Gnrhr, Lhb, and Fshb [5, 15, 19, 20]. We and others have
previously shown that these unique cell lines are excellent
model systems for investigating the molecular mecha-
nisms of gonadotrope differentiation [5, 15, 19, 21–26].
Moreover, these cell lines express the known tissue-
specific regulators of the four gonadotrope-specific differ-
entiated target genes including Sf1, Lhx3, Pitx1, Runx,
Foxl2, and Gata2 [22, 24, 25, 27–31], and their binding
sites in the proximal promoters of the gonadotrope-
specific genes have been defined either experimentally or
bioinformatically [5, 29, 32–34]. These tissue-specific
transcription factors play direct roles in regulating the
transcription of the gonadotrope-specific target genes, yet
the coordinated program of gonadotrope maturation
remains to be elucidated [35, 36]. Recent work has begun
to address this topic by analyzing the epigenetic regulation
of gonadotrope specific genes [5]. To further our under-
standing of the global chromatin status of the
gonadotrope-specific genes during gonadotrope matur-
ation, and obtain a more comprehensive understanding of
the changes in chromatin status allowing specific expres-
sion of key gonadotrope markers, we investigated chroma-
tin status and its correlation to gonadotrope gene
expression in our model pituitary lineage cell lines.
Methods
Cell culture
To establish how chromatin status on key gonadotrope
genes changes during gonadotrope cell maturation, we
studied three model immortalized mouse gonadotrope
cell lines αT1–1, αT3–1, and LβT2, as well as two con-
trol cell lines, the mouse thyrotrope cell line TαT1, and
the mouse fibroblast cell line, NIH3T3 (ATCC). All cell
lines were cultured in DMEM with 4.5% glucose (Med-
iatech Inc., Herndon, VA), 10% fetal bovine serum
(Gemini Bio, West Sacramento, CA), and 1× penicillin-
streptomycin (Life Technologies, Inc./Invitrogen, Grand
Island, NY) in 5% CO2 at 37 °C. Cells were seeded on
10 cm dishes (Nunc, Roskilde, Denmark) and harvested
at subconfluency. For hormone treatment of LβT2 cells,
cells were serum-starved for 16 h in DMEM containing
4.5% glucose, 1× penicillin-streptomycin and 0.1% bo-
vine serum albumin. Cells were then treated for 4 h
with 100 ng/ml GnRH (Sigma-Aldrich, St. Louis, MO)
± 25 ng/ml activin (Calbiochem, La Jolla, CA) before
they were harvested for the DNase sensitivity assay.
DNase sensitivity assay
Actively transcribed chromatin is characterized by being
in an open conformation, allowing easy access of tran-
scription factors to their binding sites. This open chro-
matin increases the sensitivity of the chromatin to
DNaseI. To establish to what degree the gonadotrope
promoters of model gonadotrope cell lines would in-
crease their sensitivity to DNaseI treatment during mat-
uration we performed a DNase sensitivity assay. DNase
sensitivity assay was performed as previously described
[37]. In brief, αT1–1, αT3–1, LβT2, and NIH3T3 cells
were lysed in hypotonic buffer and nuclei were isolated
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by centrifugation at 2200 g for 5 min at 4 °C. Intact nu-
clei were resuspended in 1X DNaseI Reaction Buffer
(Promega, Madison, WI) containing 2% glycerol. Equal
amounts of nuclei were added to increasing quantities of
DNaseI (Promega) in 1X DNase Reaction Buffer, ranging
from 0 units (U) to 7.5 U, and incubated at 37 °C for
5 min. DNaseI was inactivated using DNaseI Stop Solu-
tion (Promega) and incubation at 65 °C for 10 min.
Treated nuclei were lysed in Nuclei Lysis Buffer followed
by RNase A and Proteinase K digestion. Genomic DNA
was then isolated by extraction twice with phenol/
chloroform/isoamyl alcohol and once with chloroform.
DNA was ethanol precipitated and resuspended in Tris-
EDTA buffer followed by 55 °C incubation for one hour.
qPCR was performed using SYBR Green supermix and
an iQ5 real-time PCR machine (BioRad). Primer se-
quences are detailed in Table 1. Forty ng of DNA from
each treatment condition was quantitated relative to a
standard curve of dilutions of undigested DNA. Data
from each primer set were normalized to the active gene,
Actb, or to the vehicle treatment as stated in the figure
legends [37].
Chromatin immunoprecipitation (ChIP)
To evaluate transcription factor binding to key gonado-
trope gene promoters, we performed ChIP assays. ChIP
assays were performed as previously described [38]. Chro-
matin was sonicated to an average length of 300–500 bp
using a Branson Sonifier 250 (Branson Ultrasonics Corp.,
Danbury, CT). Antibodies recognizing specific histone
modifications were: anti-acetyl-Histone-H3 (06–599;
Millipore, Temecula, CA), anti-trimethyl-Histone H3-
Lys4 (07–473; Millipore), anti-dimethyl-Histone H3-Lys9
(ab1220; Abcam), all of which are ChIP-grade antibodies.
To recognize phosphorylated polymerase, ChIP-grade
anti-RNA polymerase II CTD repeat YSPTSPS
(phospho S5) (ab5131; Abcam, Cambridge, MA), was
used. Immunoprecipitated DNA and DNA from input
chromatin were analyzed for sequences of interest by
qRT-PCR using promoter-spanning primers specified in
Table 1. For ChIP assays comparing αT1–1, αT3–1,
and LβT2 chromatin, the percentage of enrichment of
antibody signal over IgG was calculated for each primer
set. IgG was the same species and source as the com-
parison antibody. Then, values for activating chromatin
marks were normalized to those for the inactive gene
Gnrh1. For repressive chromatin marks, values were
normalized to the highly active gene Actb [37–39].
Association of transcription factors by ChIP
Antibodies were ChIP grade or previously validated for
ChIP assays: anti-LHX3 (L2202, US Biological, MA)
[25], anti-PITX1 (sc-18,922X, Santa Cruz, ChIP grade).
Immunoprecipitated DNA was analyzed for sequences
of interest by qRT-PCR using promoter-specific primers
shown in Table 1. For ChIP assays comparing αT1–1,
αT3–1, and LβT2 chromatin, the percentage of enrich-
ment of antibody signal over IgG was calculated for each
primer set. Values were then normalized to those for the
inactive gene Gnrh1 [37, 38].
RNA sequencing
To establish if gene expression levels in the studied cell
lines correlated with chromatin status, we performed
RNA sequencing. RNA was isolated from αT1–1, αT1–
3, LβT2, TαT1, and NIH3T3 cells using TRIzol® (Invitro-
gen, Grand Island, NY), as per the manufacturer’s in-
structions, and treated with Turbo DNA-free DNase
Table 1 Primers used for qRT-PCR for ChIP and DNase sensitivity assays
Primer Product length Chrom-osome Localization
Name Sequence (5′-3′) Start End
Actb-F GGCCAGCGTTTGCCTTTTATGGTAATAAT 181 5 142,905,689 142,905,869
Actb-R CGAACTATCAAGACACAAAAGAAGGCTATA
Fshb-F GGTGTGCTGCCATATCAGATTCGG 280 2 107,059,594 107,059,873
Fshb-R GCATCAAGTGCTGCTACTCACCTGTG
Gnrh-F CAGCAGGTGTTGCAATTACATTCACCATTAAG 227 14 67,745,100 67,745,326
Gnrh-R CCTGTTTGGATGTGAAAGTCAAAGGGATCTC
Cga-F GAAAATGGCCAAATGCTCTC 193 4 34,893,533 34,893,725
Cga-R TGTTCCCAGCTGCACATAAG
Lhb-F CGAGTGTGAGGCCAATTCACTGG 218 7 45,420,767 45,420,984
Lhb-R GGGCCCTACCATCTTACCTGGAGC
Gnrhr-F ATCAGAAGTAACAGGGACTCCACTC 202 5 86,197,672 86,197,873
Gnrhr-R AGGCAGTAGAGAGTAGGAAAAGGAAG
Localization and product length (bp) from the UCSC Genome Browser using the Mouse Dec. 2011 (GRCm38/mm10) Assembly.
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(Ambion, Life Technology, USA). The RNA integrity
(RNA Integrity Number ≥ 9) and quantity was deter-
mined on the Agilent 2100 Bioanalyzer (Agilent, Palo
Alto, CA, USA). cDNA libraries (n = 2) were created
using the TruSeq™ RNA Sample Prep-v2 (Illumina, San
Diego, CA), using the manufacturer’s low-throughput
protocol. Indexed samples were mixed at equal concen-
trations, four samples per lane, and sequenced using the
HiSeq 2000 sequencer (Illumina). The resulting se-
quences were aligned to the mouse genome using the
Illumina Consensus Assessment of Sequence and Vari-
ation (CASAVA) software program. qRT-PCR, sequen-
cing, and alignment were performed by the UCSD
BIOGEM Core facility supported by NIH grants P30
DK063491 and P30 CA023100. Thirty-six bp, single end
sequencing of the five cell lines generated an average of
3.6 GB of sequencing data per sample with the following
characteristics: NIH3T3: 852.2 Mbp, 23.67 million reads
and passing filter % (PF%) of 75.6; αT1–1: reads, αT3–1:
933.2 Mbp, 25.92 million reads and PF% of 75.2; LβT2:
897.0 Mbp, 24.92 million reads and PF% of 67.8; and
TαT1: 887.4 Mbp, 24.65 million reads and PF% of 70.7.
Statistical analysis
All experiments were repeated independently at least
three times. In the figures, the error bars represent the
SEM. Data were analyzed by one or two-way ANOVA in
GraphPad Prism 7 (La Jolla, CA). For all analyses, the
result was considered significant if P ≤ 0.05.
Results
Chromatin density on gonadotrope-specific genes during
development
To confirm that the immortalized pituitary cell lines
expressed the key pituitary lineage markers and provide
direct quantitation of expression levels, we performed
RNA sequencing. We found that all five of the cell lines
expressed high levels of β-actin (Fig. 1a, Actb). As ex-
pected, the common gonadotrope hormone α subunit,
Cga, was expressed in all the gonadotrope lineage cell
lines, as well as the thyrotrope cell line, TαT1 [15, 18], but
not in NIH3T3 cells (Fig. 1a). The immature (αT3–1) and
mature (LβT2) pituitary cell lines both expressed Gnrhr,
whereas the gonadotrope marker, Lhb, was only expressed
by LβT2 cells. The thyrotrope cell line TαT1 [18] was the
a
b
Fig. 1 Chromatin accessibility of gonadotrope-specific genes during development. a Expression levels of gonadotrope genes in αT1–1, αT3–1, LβT2,
TαT1, and NIH3T3 cell lines (n = 2). b DNaseI sensitivity assays in NIH3T3, αT1–1, αT3–1, and LβT2 cells. DNA from nuclei was treated with increasing
concentrations of DNaseI and analyzed by qRT-PCR with primers specific to regulatory elements (Table 1). Amplicon quantities were normalized to the
active Actb gene, and qRT-PCR data are presented as the mean fraction of DNA remaining relative to Actb ± SEM
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only cell line studied expressing the thyrotrope marker
Tshb, and did not express any of the gonadotrope-specific
genes, other than the common α subunit, Cga (Fig. 1a).
We did not detect Fshb in LβT2 cells, although these cells
are known to express this mRNA as detected by the more
sensitive method of qRT-PCR. Fshb is found at low levels
that can be induced by activin treatment [19, 40, 41].
NIH3T3 cells were used as a negative control for pituitary
gene expression (Fig. 1a).
To determine if chromatin status correlates with
expression of gonadotrope genes, we investigated the
chromatin status by DNaseI sensitivity assay [42]. We
focused on chromatin accessibility of Cga, Gnrhr, Lhb,
and Fshb in the gonadotrope lineage cell lines αT1–1,
αT3–1, and LβT2, which represent different stages of
gonadotrope development. NIH3T3 cells were used as a
negative control. Actb (β-actin) is ubiquitously expressed
in all the above cell lines, reflecting an open chromatin
status, and was therefore used to normalize the DNaseI
data (Fig. 1a and b, Actb). Three classes of chromatin ac-
cessibility have been determined by this assay: closed
(repressed), poised, and open (active) [43, 44]. One of
the characteristics of chromatin is how dynamic its con-
formation is, and its capacity to compact and unfold.
Thus, degrees of compaction and opening of the DNA
are possible. Normalizing our data to the highly tran-
scribed Actb allowed us to determine the relative DNaseI
sensitivity of the studied gonadotrope genes. To reveal
the degree of accessibility of the DNA, we used increas-
ing amounts of DNaseI. As expected, we found that Cga,
Lhb, and Gnrhr were much less sensitive to DNaseI
treatment than Actb (Fig. 1b), which correlated with
gene expression levels (Fig. 1a). Unexpectedly, Fshb was
sensitive to DNaseI treatment, although to a lesser ex-
tent than Actb (Fig. 1b). However this did not correlate
with gene transcription (Fig. 1a), supporting the import-
ance of using more than one approach to study chroma-
tin status to obtain a complete image of chromatin
accessibility to transcription factors. Cga is the earliest
gonadotrope expressed gene (E11.5 in the mouse em-
bryo) and has high expression in the gonadotrope pro-
genitor αT1–1 cell line (Fig. 1a). Consistent with this,
we found an open chromatin structure in the promoter
region of Cga in this cell line (Fig. 1b, αT1–1). The chro-
matin states of all other later chromatin modifications of
gonadotrope cell lines were repressed as evidenced by
their structures being closed and resistant to DNaseI
degradation (Fig. 1b, αT1–1, Fshb, Lhb and Gnrhr). The
immature gonadotrope cell-line αT3–1 expresses both
Cga and Gnrhr (Fig. 1a). In agreement with this, we
determined the chromatin state of these genes to be
open (Fig. 1b, αT3–1). Lhb and Fshb are not expressed
in the αT3–1 cells and have closed chromatin in this cell
(Fig. 1a). Our data show that the chromatin of Lhb and
Fshb started to shift from closed to poised in the LβT2
cells (Fig. 1b, LβT2, Two-way ANOVA, followed by
Sidaks multiple comparison, p > 0.01 at 7.5 Units of
DNaseI). The only partial opening of Lhb and Fshb in
LβT2 cells is not surprising, as cells in culture are not in
the tridimensional environment they experience in vivo
and do not receive hormonal stimulation, as gonado-
tropes would in vivo, allowing them to fully activate ex-
pression of Lhb and Fshb.
Chromatin modifications of gonadotrope-specific genes
during development
Numerous modifications of chromatin and histones allow
for successful recruitment of phosphorylated RNA poly-
merase II (phospho-Pol II), which is required to initiate
transcription [10]. To determine if the opening of the
chromatin in these cell lines correlates with a change in
the acetylation and methylation signatures on the histones
binding to the promoters and allows occupation with
phospho-Pol II, we next performed ChIP assays. We used
antibodies recognizing the activating histone modification
marks histone H3 acetylation (H3Ac), and H3K4 tri-
methylation (H3K4Me3, Fig. 2), as well as recruitment of
phospho-Pol II [38, 44]. Although, Cga is highly expressed
by all three gonadotrope lineages (Fig. 1a), and the pro-
moter is sensitive to DNaseI treatment (Fig. 1b), the active
histone marks in all three cell lines were surprisingly little
enriched as compared to Gnrh1, despite recruitment of
phospho-Pol II and active transcription (Fig. 1a and 2a).
This is unexpected and is possibly due to the chosen re-
gion of study of the Cga promoter. In agreement with
both transcription levels of Gnrhr, and its promoter’s sen-
sitivity to DNaseI treatment, the Gnrhr regulatory region
went from possessing very few active histone marks in
αT1–1, to highly enriched in these marks in αT3–1 and
LβT2 cells (Fig. 2). In agreement with our findings using
the DNaseI sensitivity assay, which found the Fshb pro-
moter to be in a rather closed conformation (Fig. 1b), this
promoter exhibits only one of the chromatin marks of an
open promoter (H3Ac), but does not bind phosphorylated
polymerase II (Fig. 2). Finally, the chromatin status of Lhb
is enriched in H3Ac and recruits phosphorylated polymer-
ase II to the regulatory region somewhat in αT3–1 and
more strongly in LβT2, which correlated with transcrip-
tion in LβT2 cells where it also exhibits enrichment of
H3K4Me3 (Fig. 1a and 2).
To assess the epigenetic role of repression, we per-
formed ChIP assays to analyze the repressive histone
modifications H3K9Me2 and H3K27Me3 [45]. We found
that one or both modifications were reduced with devel-
opmental maturation on the promoters of Gnrhr and Lhb
(Fig. 3). Gnrhr loses both repressive marks in αT3–1 and
LβT2 cells, while Lhb has progressively reduced
H3K27Me3 from αT1–1 to αT3–1 and finally LβT2 and
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trends toward lower H3K9Me2 in LβT2 cells (Fig. 3).
Whereas no changes were observed on the Fshb promoter
(Fig. 3).
Sequential recruitment of developmental pituitary
transcription factors to gonadotrope-specific promoters
Opening of the chromatin, along with activating histone
modifications, promotes access to the chromatin of tran-
scription factors. It has previously been shown that the
known gonadotrope regulatory proteins PITX2 (Pitx2),
SF1 (Nr5r1), and LHX3 (Lhx3) control expression of
the mature gonadotrope markers Lhb, Fshb, and Gnrhr
[25, 46, 47]. Using RNA sequencing, we show that these
transcription factors are expressed in the gonadotrope
lineage and thyrotrope cell lines, but not in NIH3T3
a
c
b
Fig. 2 Active histone modifications and recruitment of phospho-Pol II
to gonadotrope-specific genes in gonadotrope cells. ChIP analysis using
antibodies specific to (a) H3Ac, (b) phospho-Pol II, and (c) H3K4Me3 in
αT1–1, αT3–1, and LβT2 cells. Immunoprecipitated chromatin from
αT1–1, αT3–1, and LβT2 cells was subjected to qRT-PCR. Data are
presented as fold enrichment relative to IgG, with values normalized to
Gnrh1 and expressed as mean ± SEM (n = 4). Statistical analysis by
one-way ANOVA followed by a Tukey post-hoc, * p < 0.05, ** p < 0.01,
*** p< 0.001, as indicated by bar. n.s.: non-significant
Fig. 3 Histone modifications of inactive chromatin in αT1–1, αT3–1,
and LβT2 cells. ChIP analysis was performed using antibodies specific
to H3K27Me3, and H3K9Me2. Immunoprecipitated chromatin from
αT1–1, αT3–1, and LβT2 cells was subjected to qRT-PCR. Data are
presented as fold enrichment relative to IgG, with values normalized to
Actb and expressed as mean ± SEM. Statistical analysis by one-way
ANOVA followed by a Tukey post-hoc, * p < 0.05, ** p < 0.01,
*** p < 0.001, as indicated by bar. n.s.: non-significant
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cells (Fig. 4a). Appropriately, the gonadotrope-specific
transcription factor SF1 is not expressed in thyrotropes
(TαT1) or in the gonadotrope progenitor cells (αT1–1).
To test whether the gonadotrope-specific regulatory
factors, LHX3 and PITX1, are associated with regula-
tory regions of gonadotrope promoters in any of the
studied cell lines, we performed a ChIP analysis using
LHX3 and PITX1 antibodies. ChIP analysis revealed
that both transcription factors can bind on the gonado-
trope terminal target genes (Fig. 4b, c). LHX3 is able to
bind the promoter of Cga and Gnrhr, but neither Lhb
nor Fshb exhibit binding by this method, at any of the
stages of development (Fig. 4b, LHX3). PITX1 binds
the gonadotrope-specific promoters Cga and Lhb, but
not Gnrhr nor Fshb in this assay (Fig. 4c). This suggests
the program of differentiation in these cells is not regu-
lated simply by deacetylated histones [48], but more
likely requires a timed balance of transcription factors,
co-factors, histone modifications, DNA methylation,
and/or networks to control the developmental gonado-
trope gene expression program.
To extend this further, we asked if the final differenti-
ation of the gonadotrope lineage cells required GnRH
and/or activin treatment for the proper expression of
mature gonadotrope genes. We serum starved LβT2
cells for 16 h then treated them for 4 h with 100 ng/ml
GnRH ±25 ng/ml activin and assayed the chromatin sta-
tus of the Lhb promoter for DNase sensitivity. Indeed,
activin with or without GnRH treatment promoted Lhb
promoter opening (Fig. 4d, Two-way ANOVA compared
to vehicle, p > 0.05 for activin at 2 and 5 units of DNaseI,
and p > 0.01 for activin + GnRH at 2 and 5 units of
DNaseI, p < 0.05 when comparing activin to acti-
vin + GnRH). Lhb is known to be induced by either
GnRH or activin [23]. In contrast, these treatments did
not change chromatin opening of the already opened
Cga and Gnrhr promoters and could not change the
chromatin status of Fshb (data not shown).
Discussion
Elucidation of the molecular and cellular mechanisms
underlying pituitary development and cellular specifica-
tion is critical to our understanding of reproduction and
infertility. Herein, we used three immortalized pituitary
cell lines, which have been shown to model many as-
pects of developing gonadotropes [15, 20, 49]. It is clear
that epigenetic regulation of chromatin is key in correct
gene expression and cellular maturation. In this study,
we present data showing that pituitary gonadotrope cell
lines reveal epigenetic programming that allows the se-
quential expression of pituitary hormone genes in differ-
entiation (Fig. 5).
c d
a b
Fig. 4 Pituitary transcription factor accessibility in developing gonadotrope cell lines. a Expression levels of transcription factors in NIH3T3, αT1–1,
αT3–1, LβT2, and TαT1 cell lines (n = 2). ChIP assays in αT1–1, αT3–1, and LβT2 cells were performed using antibodies specific to the transcription
factors (b) LHX3 and (c) PITX1. Immunoprecipitated chromatin was subjected to qRT-PCR. Data are presented as fold enrichment relative to IgG,
with values normalized to Gnrh1 and expressed as mean ± SEM. Statistical analysis by one-way ANOVA followed by a Tukey post-hoc, *p < 0.05,
**p < 0.01, as indicated by bar. n.s.: non-significant. d LβT2 cells were treated with GnRH and/or activin (n = 3), before DNA from nuclei were
treated with increasing concentrations of DNaseI and analyzed by qRT-PCR with primers specific to Lhb. Amplicon quantities were normalized
to untreated samples (Vehicle), and data presented as the mean fraction of DNA remaining relative to vehicle
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The anterior pituitary has five different endocrine cell
types: gonadotropes, lactotropes, corticotropes, thyro-
tropes, and somatotropes. Until now, no efficient
method has been established to isolate live gonadotropes
for in vitro cell culture. We have previously used the
Ribotag technique, which allows selection of ribosome-
associated mRNAs of specific cell-types, to isolate
gonadotrope mRNAs and process them for qRT-PCR
[50, 51]. However, as we were interested in comparing
effects of hormone treatments and transcription factors
on chromatin status, we performed this study in model
gonadotrope cell lines. We used the developmentally
staged gonadotrope cell lines, progenitor αT1–1, imma-
ture αT3–1, and mature LβT2 cell models to address
the epigenetic regulation status of gonadotrope-specific
genes (Cga, Gnrhr, Fshb, and Lhb) during gonadotrope
maturation.
Studies of the chromatin state of Cga shows that it is
open at a very early stage represented by αT1–1 cells,
while Gnrhr chromatin opens at an immature develop-
mental stage represented by αT3–1. These correlate
directly with recruitment of phospho-Pol II and mRNA
expression (Fig. 5). The Lhb and Fshb genes only begin
to show relaxation of chromatin status in the more de-
velopmentally mature cell lines, αT3–1 and LβT2. This
opening of the chromatin correlates with the appearance
of positive, and loss of negative, histone modifications,
which correlates with specific gene expression. We
found that both Gnrhr and Lhb, though not Fshb, have
progressive increases in phospho-Pol II, H3Ac and/or
H3K4Me3, as well as a loss of H3K27Me3 and/or
H3K9Me2 from the progenitor αT1–1 and immature
αT3–1, to the mature LβT2 (Fig. 5). This partial correl-
ation between chromatin state and gene transcript levels
was recently described in αT1–1, αT3–1, and LβT2
cells, where Laverriere et al. were unable to detect Fshb
and found the Lhb promoter to be equally sensitive to
DNaseI treatment in αT1–1, αT3–1, and LβT2, despite
transcription of Lhb specifically in LβT2 cells [5]. Inter-
estingly, despite lack of Fshb transcription in the mouse
fibroblast cell line, NIH3T3, our DNaseI sensitivity assay
found the Fshb regulatory region to be relatively sensi-
tive to DNaseI. DNaseI Chip-seq of NIH3T3 cells has
been done previously and is available on the USCS gen-
ome browser (consulted July 25, 2017). The deposited
data set was generated using a different DNaseI protocol
from ours, using a single DNaseI concentration, and
showed the Fshb and Lhb regulatory regions to be in
relatively closed conformations. However, by comparing
chromatin status and transcription factor occupancy of
Fig. 5 Summary of gonadotrope gene transcription, transcription factor occupancy and chromatin changes in gonadotrope cells. During gonadotrope
maturation, illustrated here by the progenitor αT1–1, immature αT3–1, and mature LβT2 cells, the chromatin status changes from a closed
conformation on Gnrhr, Lhb and Fshb (enrichment in H3K27Me3 and H3K9Me2) in αT1–1, to a more open conformation in LβT2 cells (increase in H3Ac,
and H3K4Me3), which is associated with enhanced expression of Lhb and Gnrhr (+). The progressive opening of the Lhb promoter allows recruitment of
the transcription factors (TXN factors) PITX1 and SF1 [68], whereas opening of the Gnrhr promoter allows recruitment of SF1 and LHX3 [69]. The
regulatory region of the α-subunit Cga is in an open confirmation during all the stages of maturation, and associated with recruitment of PITX1 and LHX3
and high mRNA expression (+++). The discrete opening of the Fshb promoter during gonadotrope maturation allows association of SF1 and LHX3 to the
regulator region of Fshb [70, 71]. Depending on study conditions, Fshb transcript is undetectable or can be detected at low levels in LβT2 cells
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the Fshb regulatory region of numerous studies depos-
ited on the USCS genome browser, we found the up-
stream region of Fshb to be able to bind transcription
factors including REST (repressor element-1 silencing
transcription factor), which is a known repressor of tran-
scription [52]. Thus, it is very likely that the DNaseI sen-
sitivity of the Fshb regulatory region, in NIH3T3 cells in
our assay, shows some degree of opening. In addition,
approximately 1 Kb upstream of the transcriptional start
site of Fshb is a SINE repeat [53], which can allow
expression in many different cell lines, and thus could
confer a DNaseI sensitive region upstream of the Fshb
gene. Interestingly, a SINE repeat has been found within
intron 1 of the pig Fshb gene, which affects Fshb expres-
sion and reproductive function in pigs [54]. It will there-
fore be of interest in future studies to address the role of
the SINE repeats upstream of the mouse Fshb transcrip-
tion start site, to determine if these also impact Fshb
expression in gonadotrope cell lines.
As expected, Cga, which is highly transcribed in all
three cell lines, did not have significant differences be-
tween the cell lines in histone modifications or
phospho-Pol II occupation. Although we and others [5]
did not detect Fshb mRNA in any of the three studied
cell lines without using highly sensitive qRT-PCR or
activin treatment, Fshb does start to gain H3Ac histone
modifications in LβT2 cells as well. Since Fshb is de-
tected at low levels, and only using qRT-PCR in LβT2
cells [55], it is not unexpected that histone modifications
may reflect a less active status (Fig. 5). We believe that
the low expression of Fshb in LβT2 cells is due to the
relatively simple milieu in which the cell lines are main-
tained, in comparison to the broad range of stimuli and
hormones received by gonadotropes in vivo. The low ex-
pression of Fshb is possibly mediated by HDAC. It was
previously shown that a GnRH treatment or inhibition
of HDACs in αT3–1 cells allowed rapid expression of
both Lhb and Fshb [56]. This confirms that αT3–1 cells
possess all of the required transcriptional machinery to
initiate expression of Lhb and Fshb, but removal of
HDACs, particularly HDAC4 from these promoters is
required to actively transcribe Lhb and Fshb [56]. Based
on this, we hypothesized that hormonal treatment of
LβT2 cells would allow opening of the chromatin of
these genes. Thus, we treated LβT2 cells with activin ±
GnRH. Indeed, activin significantly promoted Lhb pro-
moter opening in LβT2 cells with or without GnRH,
however we were unable to detect opening of the Fshb
promoter in any of the studied conditions (not shown).
As GnRH alone was inefficient in opening the chromatin
of the Lhb promoter, perhaps due to the tonic as op-
posed to pulsatile treatment or the single time point of a
4-h exposure. GnRH does induce Lhb gene expression
but may act without further opening the chromatin.
Prior studies have shown that an increase in GnRH
pulse frequency favors Lhb expression [57, 58], while a
decrease favors Fshb gene expression [59–61]. To fur-
ther our understanding of chromatin status of gonado-
trope genes, and their response to hormone treatment, it
will be of interest to expand the presented studies using
Chip-seq, which allows the study of enhancers as well as
other regulatory regions, in combination with ATAC-
seq, a technique which has been shown to be more pre-
cise than H3K27Ac in identifying active promoters [62].
To establish the relationship between molecular and
epigenetic mechanisms in gonadotropes, we investigated
the accessibility of the transcription factors, LHX3, and
PITX1, to bind gonadotrope-specific gene promoters in
the studied cell lines [63–67]. Interestingly, the regulatory
proteins PITX1/2, SF1, and LHX3 were all present in the
intermediate gonadotrope cell line (αT3–1), and some
even in αT1–1 (PITX1/2, and LHX3). By comparing chro-
matin status and transcription factor access to the chro-
matin, our data indicate that LHX3 is important in early
and maintained expression of Cga. In agreement with pre-
vious studies [25, 31], the opening of the Gnrhr promoter
in αT3–1 cells allowed increased association of LHX3 with
the promoter, whereas the increased opening of the Lhb
promoter correlated with recruitment of PITX1 (Fig. 5)
[68]. In our hands, the Fshb promoter was in a rather
closed configuration, not allowing detectable association
of transcription factors with this gene.
Conclusion
Our data show exciting new evidence of gonadotrope-
specific chromatin changes taking place during develop-
ment using immortalized model gonadotrope cell lines.
Although the cell lines utilized remain an in vitro sys-
tem, representative of developing gonadotrope cell lines,
we show a progressive opening of the gonadotrope-
specific gene promoters, Cga, Gnrhr, Lhb, and Fshb in
these model cell lines and demonstrate that these pro-
moters are not only controlled by developmental tran-
scription factors, but also by epigenetic mechanisms that
include the modulation of chromatin structure, and his-
tone modifications.
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